Clinical

The AJMC^® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care^® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.

Latest News

GLP-1 receptor agonists | Image Credit: K KStock - stock.adobe.com

GLP-1 Receptor Agonists Show Promise as Adjunctive Treatment for Ovarian Cancer

By Brooke McCormick

July 11th 2025

Glucagon-like peptide-1 (GLP-1) receptor agonists significantly enhance overall survival in patients with ovarian cancer, offering a promising adjunct to traditional treatments.

Arthritis | Image Credit: Evrymmnt - stock.adobe.com

Gaps in Arthritis Subtype Awareness Highlight Health Literacy Disparities Among US Adults

By Brooke McCormick

July 10th 2025

Medical personnel filing a syringe needle | Image Credit: MargJohnsonVA - stock.adobe.com.jpeg

SGLT2 Inhibitor Offers Kidney Protection and Reduces Heart Failure Risk After Acute Myocardial Infarction

By Giuliana Grossi

July 10th 2025

US map | Image Credit: iiierlok_xolms - stock.adobe.com

Disparities Persist Despite Declining US Ovarian Cancer Death Rates

By Brooke McCormick

July 9th 2025

COVID-19 3D rendering | Image Credit: Production Perig - stock.adobe.com

Severe COVID-19 Linked to Higher Exacerbation, Mortality Risks in Patients With Bronchiectasis

By Brooke McCormick

July 8th 2025

More News

Raising the Bar on Cardiovascular Benefit

Raising the Bar on Cardiovascular Benefit

Watch

Examining Cardiovascular Outcomes Trials

Examining Cardiovascular Outcomes Trials

Watch

GLP-1 Receptor Agonists and Cardiovascular Benefit

GLP-1 Receptor Agonists and Cardiovascular Benefit

Watch

Understanding the Safety Data in CANVAS

Understanding the Safety Data in CANVAS

Watch

Practical Implications of the CANVAS Trial

Practical Implications of the CANVAS Trial

Watch

Diabetes: Shifting Mindset for Cardiovascular Benefits

Diabetes: Shifting Mindset for Cardiovascular Benefits

Watch

Complexities in Diabetes Care in 2017

Complexities in Diabetes Care in 2017

Watch

The Potential Role of PCSK9 Inhibitors for Patients With Hyperlipidemia

The Potential Role of PCSK9 Inhibitors for Patients With Hyperlipidemia

Watch

Role of the Health Plan in Providing Support to Members With Diabetes

Role of the Health Plan in Providing Support to Members With Diabetes

Watch

The Role of PCSK9 Inhibitors for Patients with Hyperlipidemia

The Role of PCSK9 Inhibitors for Patients with Hyperlipidemia

Watch

An Increased Emphasis on Individual Risk Factors and Goals

An Increased Emphasis on Individual Risk Factors and Goals

Watch

Impact of Cost on Patients' Access to Treatment

Impact of Cost on Patients' Access to Treatment

Watch

How Drug Cost Influences Drug Selection

How Drug Cost Influences Drug Selection

Watch

Role of Early Intervention in Preventing Progression to T2D

Role of Early Intervention in Preventing Progression to T2D

Watch

Major Cost Drivers in T2D Management

Major Cost Drivers in T2D Management

Watch

Updates to Treatment Guidelines: Effects on Payers

Updates to Treatment Guidelines: Effects on Payers

Watch

Advantages of Medications that Treat Multiple Conditions

Advantages of Medications that Treat Multiple Conditions

Watch

Management of Hyperlipidemia in Patients With Liver Impairment or Renal Impairment

Management of Hyperlipidemia in Patients With Liver Impairment or Renal Impairment

Watch

Considerations Regarding Statin Therapy

Considerations Regarding Statin Therapy

Watch

Role of Clinical Practice Guidelines in the Management of Diabetes and Diabetes-Related Complications

Role of Clinical Practice Guidelines in the Management of Diabetes and Diabetes-Related Complications

Watch

Addressing the Effect of Polypharmacy on Medication Adherence

Addressing the Effect of Polypharmacy on Medication Adherence

Watch

The Role of Managed Care in Identifying and Counseling Patients With Prediabetes

The Role of Managed Care in Identifying and Counseling Patients With Prediabetes

Watch

Partnering With Providers to Prevent or Delay Complications Related to Diabetes

Partnering With Providers to Prevent or Delay Complications Related to Diabetes

Watch

WellCare's Initiatives To Improve Care for Members With Diabetes

WellCare's Initiatives To Improve Care for Members With Diabetes

Watch

Alternatives to Add-On Therapy for T2D and Hyperlipidemia

Alternatives to Add-On Therapy for T2D and Hyperlipidemia

Watch

The Influence of Lipid Guidelines on Real-World Practice Patterns

The Influence of Lipid Guidelines on Real-World Practice Patterns

Watch

Variables Involved When Adding Medications to Treat Diabetes

Variables Involved When Adding Medications to Treat Diabetes

Watch

How Does the Potential for Weight Gain Influence Choice of Therapies?

How Does the Potential for Weight Gain Influence Choice of Therapies?

Watch

Comparison of Guidelines From ADA and AACE

Comparison of Guidelines From ADA and AACE

Watch

Complications of Diabetes and Role of Insulin Resistance in Metabolic Syndrome

Complications of Diabetes and Role of Insulin Resistance in Metabolic Syndrome

Watch

...

246 247 248 249 250 251 252 253 254

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions